See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
NFL
Social Media
Soccer
Cricket
Catholic Church
Donald Trump
Natural Disasters
Premier League
Baseball
Rugby
Artificial Intelligence
Published • loading... • Updated

FDA Authorizes First Prescription Digital Therapeutic for Migraine

Summary by Medscape
The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine. Medscape Medical News

2 Articles

All
Left
Center
Right
MedscapeMedscape

FDA Authorizes First Prescription Digital Therapeutic for Migraine

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine. Medscape Medical News

·United States
Read Full Article
pharmatimes.compharmatimes.com

FDA approves Click’s digital therapeutic for episodic migraine

More than 37 million adults in the US are affected by migraine

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmatimes.com broke the news in on Thursday, April 17, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical

Medical

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal